Interferon α therapy in patients with chronic hepatitis C infection: quality of life and depression

Interferon α therapy in patients with chronic hepatitis C infection: quality of life and depression

Health-related quality of life was examined in 49 patients with hepatitis C virus with no psychiatric history who received interferon (IFN)-α treatment. Quality of life was assessed at baseline, at 3-time points during IFN-α therapy and at 1-6 month follow-up, using SF-36. Hepatitis C virus patients...

Full description

Bibliographic Details
Main Authors:	Ciro Conversano, Claudia Carmassi, Marina Carlini, Giulia Casu, Paola Gremigni, Liliana Dell’Osso
Format:	Article
Language:	English
Published:	MDPI AG 2015-03-01
Series:	Hematology Reports
Subjects:	depression, HCV, interferon, quality of life
Online Access:	http://www.pagepress.org/journals/index.php/hr/article/view/5632

Similar Items

Impact of Interferon-Based Therapy on Hepatitis C-Associated Rheumatic Diseases: A Nationwide Population-Based Cohort Study
by: Jur-Shan Cheng, et al.
Published: (2021-02-01)

Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
by: Tujana Boldanova, et al.
Published: (2017-06-01)

Treatment of hepatitis C virus infection: From therapy with interferon to direct-acting antivirals
by: Laura Lopera, et al.
Published: (2023-01-01)

HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV)
by: Tomasz Pawlowski, et al.
Published: (2023-03-01)

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon
by: Sandro da Costa Ferreira, et al.

Evaluation of the effect of soybean diet on interferon-α-induced depression in male mice
by: Yazdan Azimi Fashi, et al.
Published: (2017-08-01)

Treatment Efficacy of Sofosbuvir and Ribavirin Combination at Two Weeks in Chronic Hepatitis C
by: Aqsa Naseer
Published: (2017-12-01)

A Human and Rhesus Macaque Interferon-Stimulated Gene Screen Shows That Over-Expression of <i>ARHGEF3/XPLN</i> Inhibits Replication of Hepatitis C Virus and Other Flavivirids
by: Connor G. G. Bamford, et al.
Published: (2022-07-01)

Association of HCV Load and Interferon Therapeutic Response with Gender in Hepatitis C Patients Presenting to a Tertiary Care Health Facility, Rawalpindi
by: Mahnoor Javed Janjua
Published: (2018-11-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

Predictive Genetic Variations in the Kynurenine Pathway for Interferon-α-Induced Depression in Patients with Hepatitis C Viral Infection
by: Szu-Wei Cheng, et al.
Published: (2021-03-01)

Association between Hepatitis C Virus Infection and Esophageal Cancer: An Asian Nationwide Population-Based Cohort Study
by: Yin-Yi Chu, et al.
Published: (2021-05-01)

Interferon-inducible SAMHD1 restricts viral replication through downregulation of lipid synthesis
by: Ni An, et al.
Published: (2022-11-01)

Depression and Cognitive Dysfunction in Patients with Chronic Hepatitis C: Correlation with Viral Replication in the Peripheral Blood Mononuclear Cells and Cytokines in Serum
by: Marek Radkowski, et al.
Published: (2023-10-01)

Long-term renal function alterations in hepatitis C patients with SVRs: Impacts of therapies and mixed cryoglobulinemia
by: Ming-Ling Chang, et al.
Published: (2024-03-01)

Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life Study
by: Vincenzo Messina, et al.
Published: (2020-12-01)

The interferons : characterization and application /
by: Meager, Anthony
Published: (2006)

Depression and anxiety disorders during pegylated interferon treatment in patients with chronic hepatitis B
by: Ozen Onen Sertoz, et al.
Published: (2017-01-01)

Interferon therapy and its association with depressive disorders – A review
by: Jing Yung Lai, et al.
Published: (2023-02-01)

Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)
by: Bernhard Schlevogt, et al.
Published: (2021-10-01)

Interferon-Stimulated SAMHD1 Restricts Hepatitis C Virus Replication
by: Ni An, et al.
Published: (2020-06-01)

HCV-induced autophagy and innate immunity
by: Jiyoung Lee, et al.
Published: (2024-02-01)

HCV carriers with normal aminotransferase levels: “normal” does not always mean “healthy”
by: Claudio Puoti
Published: (2013-04-01)

EFFICACY OF INTRAPERITONEAL INTERFERON-α ADMINISTRATION FOR TREATMENT OF ENDOMETRIOSIS IN RATS
by: R. V. Pavlov, et al.
Published: (2014-07-01)

Hepatitis C virus quantification in serum and saliva of HCV-infected patients
by: Gisele Barreto Lopes Menezes, et al.
Published: (2012-08-01)

Multisystem sarcoidosis in a patient on interferon-α therapy for chronic hepatitis C
by: Bouchra Oudghiri, et al.
Published: (2012-01-01)

Protection of Ducklings from Duck Hepatitis A Virus Infection with ELPylated Duck Interferon-α
by: Yongjuan Wang, et al.
Published: (2022-03-01)

Study of the Hepatitis C Virus in the Republic of Macedonia
by: Plaseska-Karanfilska Dijana, et al.
Published: (2012-12-01)

Role of Erythropoietin in Adherence to Antiviral Treatment in Hepatitis C
by: Rizwan Ahmed
Published: (2013-06-01)

Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies
by: Barbara Infante, et al.
Published: (2022-12-01)

Interferons and hepatitis C virus
by: Markus H. Heim
Published: (2012-05-01)

Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection Neumonitis intersticial secundaria a tratamiento con interferón pegilado
by: J. Torres Macho, et al.
Published: (2010-10-01)

Treatment with Ad5-Porcine Interferon-α Attenuates Ebolavirus Disease in Pigs
by: Chandrika Senthilkumaran, et al.
Published: (2022-04-01)

A longitudinal study of post-traumatic stress, depressive, and anxiety symptoms trajectories in subjects with bipolar disorder during the COVID-19 pandemic
by: Claudia Carmassi, et al.
Published: (2022-01-01)

Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence
by: DeGaulle I. Chigbu, et al.
Published: (2019-04-01)

Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
by: Darius Moradpour, et al.
Published: (2012-02-01)

Induction Strategies for Interferon-α2B Production in Periplasmic Space of Escherichia Coli
by: Azaman, Siti Nor Ani
Published: (2011)

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
by: Kamil Grubczak, et al.
Published: (2021-07-01)

Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection
by: Anna Paola Carreca, et al.
Published: (2022-07-01)

Interferons and interferon-related pathways in heart disease
by: Duc Tin Tran, et al.
Published: (2024-04-01)